. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: J Heart Lung Transplant. 2015 Oct 30;35(3):362–369. doi: 10.1016/j.healun.2015.10.028

Table 4a. Association between Age Groups and 5-Year Mortality among Transplant Recipients from April 1, 1995 to March 27, 2014.

		Unadjusted		Adjusted ^a
Outcome	Variable	HR (95% CI)	P-value	HR (95% CI)	P-value
5-Year Mortality	Age (60-69) vs. Age (18-59)	1.12 (1.07, 1.18)	<.001	1.13 (1.07, 1.18)	<.001
	Age (70+) vs. Age (18-59)	1.29 (1.10, 1.51)	0.001	1.35 (1.16, 1.58)	<.001
	Age (70+) vs. Age (60-69)	1.15 (0.98, 1.34)	0.09	1.20 (1.03, 1.41)	0.02

Adjustment variables: Recipient: gender, race, ischemic etiology, creatinine, condition at transplant, mechanical support (ECMO, IABP, ventilator, or other), pharmacological support (prostaglandins, inotropes, or inhaled NO), diabetes. Donor: ischemic time, age, diabetes, smoking history, cause of death (head trauma, stroke, anoxia, other). Gender mismatch. Year of transplant.